摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(11aS)-1,2,3,10,11,11a-hexahydro-5H-pyrrolo-<2,1-c><1,4>benzodiazepin-5-one | 94811-92-4

中文名称
——
中文别名
——
英文名称
(11aS)-1,2,3,10,11,11a-hexahydro-5H-pyrrolo-<2,1-c><1,4>benzodiazepin-5-one
英文别名
1,2,3,10,11,11a-hexahydro-5H-pyrrolo<2,1-c><1,4>benzodiazepin-5-one;(11aS)-1,2,3,10,11,11a-hexahydro-5H-pyrrolo<2,1-c><1,4>benzodiazepine-5-one;1,2,3,10,11,11a-hexahydro-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one;(S)-2,3,11,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5(10H)-one;(S)-1,2,3,10,11,11a-hexahydro-5H-benzo[e]pyrrolo[1,2-a][1,4] diazepin-5-one;(11aS)-1,2,3,10,11,11a-hexahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one;(6aS)-5,6,6a,7,8,9-hexahydropyrrolo[2,1-c][1,4]benzodiazepin-11-one
(11aS)-1,2,3,10,11,11a-hexahydro-5H-pyrrolo-<2,1-c><1,4>benzodiazepin-5-one化学式
CAS
94811-92-4
化学式
C12H14N2O
mdl
——
分子量
202.256
InChiKey
HYPFMFLAOOULNZ-VIFPVBQESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    15
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    32.3
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Novel biocatalytic reduction of aryl azides: chemoenzymatic synthesis of pyrrolo[2,1-c][1,4]benzodiazepine antibiotics1
    作者:Ahmed Kamal、Y. Damayanthi、B. S. Narayan Reddy、B. Lakminarayana、B. S. Praveen Reddy
    DOI:10.1039/a701249g
    日期:——
    The chemoselective reduction of aryl azides to aryl amines, and the synthesis of the imine-containing pyrrolo[2,1-c]- [1,4]benzodiazepine DNA-binding antitumour antibiotics by selective biocatalytic reductive cyclization of azido aldehydes, has been achieved by employing baker’s yeast.
    通过使用面包酵母,成功实现了对芳基叠氮化合物进行化学选择性还原生成芳基胺,并通过选择性生物催化还原环化叠氮醛合成含亚胺的吡咯并[2,1-c][1,4]苯并二氮杂䓬类DNA结合抗癌抗生素。
  • Biphenyl derivatives and drug composition
    申请人:Wakamoto Pharmaceutical Co., Ltd.
    公开号:US06225306B1
    公开(公告)日:2001-05-01
    A biphenyl derivative represented by the following general formula (1) and a pharmaceutically acceptable salt thereof: [In the formula (1), A represents a single bond, —CH2—, —CO—, —CS— or —SO2—; B represents a single bond or —CH2—; R1 represents a hydrogen atom, —OH, —NR11R12 (wherein R11 and R12 each independently represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms), —OCOCH3, or a halogen atom; R2 represents a hydrogen atom or R1 and R2 form a group ═O together; R3 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms; provided that in the formula, the absolute configuration of the position a may be either R or S]. The compound of the present invention has considerably high safety and efficacy and is useful as, in particular, a vasopressin receptor antagonist.
    由以下一般式(1)表示的联苯衍生物和其药学上可接受的盐:[在式(1)中,A代表单键,—CH2—,—CO—,—CS—或—SO2—;B代表单键或—CH2—;R1代表氢原子,—OH,—NR11R12(其中R11和R12各自独立地代表一个氢原子或具有1至4个碳原子的烷基基团),—OCOCH3或卤素原子;R2代表氢原子或R1和R2共同形成一个羟基;R3代表氢原子或具有1至4个碳原子的烷基基团;在该式中,位置a的绝对构型可以是R或S]。本发明的化合物具有相当高的安全性和有效性,并且特别适用作为抗利尿激素受体拮抗剂。
  • Acceptorless dehydrogenative construction of CN and CC bonds through catalytic aza-Wittig and Wittig reactions in the presence of an air-stable ruthenium pincer complex
    作者:Nandita Biswas、Kalicharan Das、Bitan Sardar、Dipankar Srimani
    DOI:10.1039/c8dt04725a
    日期:——
    aza-Wittig type reaction. The reaction is catalyzed by an acridine-derived ruthenium pincer complex and does not use any oxidant. The present protocol offers a wide substrate scope, including aliphatic, aryl or heteroaryl alcohol/azides. This expeditious protocol was successfully applied to construct a CC bond directly from alcohol via dehydrogenative Wittig reaction. Furthermore, the synthesis of structurally
    C N键的构建是通过aza-Wittig型反应将醇与叠氮化物进行脱氢偶联而实现的。该反应由an啶衍生的钌钳配合物催化,并且不使用任何氧化剂。本协议提供了广泛的底物范围,包括脂族,芳基或杂芳基醇/叠氮化物。该快速方案已成功应用于通过脱氢Wittig反应直接从醇中构建C C键。此外,通过该方法还可以合成结构上重要的吡咯并[1,4]苯并二氮杂衍生物。
  • Synthesis of pyrrolo[2,1-c][1,4]benzodiazepine antibiotics: Oxidation of cyclic secondary amine with TPAP
    作者:Ahmed Kamal、Philip W Howard、B.S Narayan Reddy、B.S Praveen Reddy、David E Thurston
    DOI:10.1016/s0040-4020(97)00033-1
    日期:1997.3
    A facile procedure for the preparation of the imine form of the pyrrolo[2,1-c][1,4]-benzodiazepine ring system by the oxidation of cyclic secondary amine with catalytic amounts of tetra-n-propylammonium perruthenate (TPAP) and N-methylmorpholine N-oxide (NMO) as a co-oxidant is described. This oxidative method is devoid of side-products and is thus a significant improvement over the Swern oxidation
    通过催化量的四正丙基过钌酸铵(TPAP)氧化环仲胺氧化吡咯并[2,1- c ] [1,4]-苯并二氮杂ring环系统的亚胺形式的简便方法描述了作为辅助氧化剂的N-甲基吗啉N-氧化物(NMO)。这种氧化方法没有副产物,因此比以前报道的Swern氧化有很大的改进。
  • Pyrrolobenzodiazepines as key intermediates in the synthesis of dimeric cytotoxic pyrrolobenzodiazepines
    申请人:Howard Wilson Philip
    公开号:US20070191309A1
    公开(公告)日:2007-08-16
    Compounds and a method of synthesis of compounds of formula (Ia) or (Ib): and salts, solvates, and chemically protected forms thereof, wherein the dotted lines indicate the optional presence of a double bond between C1 and C2 or C2 and C3; R 2 and R 3 are independently selected from —H, ═O, ═CH 2 , —CN, —R, OR, halo, ═CH—R, O—SO 2 —R, CO 2 R and COR; R 10 is a carbamate-based nitrogen protecting group; and R 11 is an oxygen protecting group.
    化合物及其合成方法公式(Ia)或(Ib)的化合物:以及其盐、溶剂化物和化学保护形式,其中点线表示C1和C2或C2和C3之间存在双键的可选存在;R2和R3独立地选择自—H,═O,═CH2,—CN,—R,OR,卤素,═CH—R,O—SO2—R,CO2R和COR;R10是基于碳酸酯的氮保护基;R11是氧保护基。
查看更多